AI in Action: How AUTOMA+ 2025 Is Transforming Pharmaceutical Operations and Patient Care
AUTOMA+ 2025 in Austria gathers pharma leaders to explore AI in drug development, manufacturing, and patient care. Experts will share insights on AI-driven innovation and digitalisation.

Pharmaceutical Automation and Digitalisation Congress: AI in Action at AUTOMA+ 2025
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025 gathers decision-makers and digital innovators to exchange insights on AI integration within pharmaceutical operations. The event will take place in Vösendorf, Austria, on November 24-25, serving as a focal point for networking and knowledge sharing.
AI adoption is transforming industries globally, and the pharmaceutical sector is actively embracing this shift. Companies like Eli Lilly invest in AI to improve R&D functions, with a focus on lab automation and medical reporting. Bayer is leveraging AI technologies to speed up product development and optimize manufacturing and delivery processes.
Genentech, part of the Roche Group, introduced the “lab in a loop” concept, where generative AI uses data from labs and clinics to train models. These models then predict drug targets and therapeutic molecules, streamlining drug discovery and development.
AI Across the Pharma Value Chain
AUTOMA+ 2025 will showcase the latest AI strategies applied across the pharmaceutical value chain, including packaging, labelling, manufacturing, labs, and logistics.
Harald Schnidar, CEO and Founder of SCARLETRED Holding GmbH, highlights the lasting impact of combining automation with AI: “Automation combined with AI is a huge opportunity that we should harvest together. It is not just a trend, so it will stay forever.”
SCARLETRED Holding GmbH develops certified software as medical device products and AI-driven data analysis services. Their solutions standardize skin imaging to objectively assess diseases and treatments, enhancing data collection in clinical trials and routine care.
Expert Insights and Discussions
The AUTOMA+ 2025 speaker lineup features experts from Albocensa, Bayer Austria Ges.m.b.H., Automators GmbH, Acino Pharma AG, LETI Pharma, Sapio Sciences, Innowise, Cipla Ltd, SCARLETRED Holding GmbH, and others. These leaders will share practical insights on AI implementation in pharma.
During the executive opening panel “Smart Pharma: leveraging digital technologies of tomorrow,” Harald Schnidar will discuss AI’s role in clinical skin drug R&D and remote patient care.
Nandan Kulkarni, Head of Diagnostics and Medical Technologies, emphasizes digitalisation’s importance in creating a patient-centric ecosystem: “Digitalisation is one of the important elements to bring access and affordability. We are in the era where digitalisation is our only solution to reach millions of patients in chronic therapies, at the same time making sure we are creating impact on their lives.”
Kulkarni also predicts that within five years, AI and mobile applications will merge to form a global digital ecosystem for patients.
Automation and AI Integration Insights
Vitaly Levashov from Innowise, who participated last year, shared valuable takeaways: the pharma industry is focusing more on automation and AI integration to streamline operations, reduce costs, and improve patient outcomes.
This year, Innowise will join the leaders talk “AI-powered pharma: unmasking the future,” where Roman Sen, Head of IT and Life Sciences, and speakers from ZETA GmbH, Sapio Sciences, and Takeda will discuss innovative digital approaches, AI in remote patient care, and the deployment of AI solutions in healthcare systems.
Why AUTOMA+ Matters for Product Development Professionals
As AI becomes more embedded in pharmaceutical processes, AUTOMA+ offers product development professionals a chance to deepen their understanding of AI tools and connect with industry leaders. The event highlights practical applications and shares strategies that can be integrated into product development pipelines to enhance efficiency and innovation.
For those interested in expanding their AI knowledge relevant to pharma and product development, exploring targeted AI courses can provide additional skills and insights. Visit Complete AI Training: Courses by Job for tailored learning paths.
Learn more about the AI technologies featured at AUTOMA+ 2025 here: AUTOMA+ 2025 AI Technologies.